What investment strategy does Flerie focus on?

Flerie focuses on VC, Growth strategies in the private equity space.

How many portfolio companies does Flerie have?

Flerie has 25 active portfolio companies and 4 completed exits and 1 fund tracked on GP Intel.

Where is Flerie headquartered?

Flerie is headquartered in Stockholm, Sweden.

What is Flerie's assets under management?

Flerie manages approximately €300M in assets under management.

What sectors does Flerie invest in?

Flerie invests across Healthcare.

What are Flerie's recent exits?

Recent realized exits by Flerie include: Cobra Biologics (2020) to Cognate BioServices; Cormorant Pharmaceuticals (2016) to Bristol Myers Squibb.

Home/GPs/Flerie

DetailCard

Flerie

Stockholm, Sweden·Founded 2011·

Venture Capital Growth Equity

·flerie.com

Flerie is a Stockholm-based, publicly listed evergreen life-science investment company that takes long-term direct minority and majority stakes in biotech, pharma-services and drug-development businesses across the Nordics, wider Europe, Israel and the US. Founded in 2011 by Recipharm co-founder Thomas Eldered, it listed on Nasdaq Stockholm in June 2024 through a reverse merger with InDex Pharmaceuticals and trades as Flerie AB (publ) under the ticker FLERIE.

AUM

€300M

Funds

vintages 2011

Portfolio

Exits

Flerie is a Stockholm venture capital firm with €300M AUM, 25 active companies and 4 exits.

SectorsHealthcare

Key takeaways

·Average hold across 4 realized deals: 7 years.
·Top sector focus: Biotech (69% of portfolio).

Sector breakdown

29 companies

Biotech

20 · 69%

Pharma

6 · 21%

MedTech

2 · 7%

ClimateTech

1 · 3%

Geography breakdown

7 geographies

Sweden

19 · 66%

3 · 10%

Netherlands

1 · 3%

Iceland

1 · 3%

Germany

1 · 3%

Israel

1 · 3%

Key facts

HQStockholm, Sweden

Founded2011

Websiteflerie.com

Recent exits

Flerie exited A3P Biomedical in 2025 after 3 years.

Flerie exited Provell Pharmaceuticals in 2025 after 12 years.

Flerie sold Cobra Biologics to Cognate BioServices in 2020 after 9 years.

Flerie sold Cormorant Pharmaceuticals to Bristol Myers Squibb in 2016 after 4 years.

Coverage notes

1 fund tracked, 29 portfolio companies (25 active · 4 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Flerie has raised, with its portfolio companies. Hand-checked from public filings.

1 fund

Fund

Strategy

Vintage

Size

Assets

Exits

Flerie InvestActive

Life Sciences VC201125 assets4 exits

Life Sciences VC

2011 · 15yr

–

Unrealized

25 held

Company	Entry
Alder Therapeutics Biotech · Sweden	2022
Amarna Therapeutics Biotech · Netherlands	2018
AnaCardio Biotech · Sweden	2022
Atrogi Biotech · Sweden	2017
Bohus Biotech Pharma · Sweden	2022
Bonsai Biotherapeutics Biotech · Sweden	2021
Buzzard Pharmaceuticals Biotech · Sweden	2021
Chromafora ClimateTech · Sweden	2014
Egetis Therapeutics Biotech · Sweden	2017
Empros Pharma Biotech · Sweden	2013
EpiEndo Pharmaceuticals Biotech · Iceland	2021
Frontier Biosolutions Pharma · Germany	2023
Geneos Therapeutics Biotech · US	2022
KAHR Medical Biotech · Israel	2012
Lipum Biotech · Sweden	2021
Mendus Biotech · Sweden	2023
Microbiotica Biotech · UK	2022
Nanologica Biotech · Sweden	2014
NorthX Biologics Pharma · Sweden	2021
Prokarium Biotech · UK	2014
Strike Pharma Biotech · Sweden	2022
Symcel MedTech · Sweden	2013
Vitara Biomedical MedTech · US	2022
Xintela Biotech · Sweden	2022
Xspray Pharma Pharma · Sweden	2021

Realized

4 exits

Company	Entry	Exit	Type	Buyer	MOIC
A3P Biomedical Biotech · Sweden	2022	2025	Secondary	–	–
Cobra Biologics Pharma · UK	2011	2020	Trade Sale	Cognate BioServices	–
Cormorant Pharmaceuticals Biotech · Sweden	2012	2016	Trade Sale	Bristol Myers Squibb	–
Provell Pharmaceuticals Pharma · US	2013	2025	–	–	–

Frequently asked questions

What investment strategy does Flerie focus on?: Flerie focuses on VC, Growth strategies in the private equity space.
How many portfolio companies does Flerie have?: Flerie has 25 active portfolio companies and 4 completed exits and 1 fund tracked on GP Intel.
Where is Flerie headquartered?: Flerie is headquartered in Stockholm, Sweden.
What is Flerie's assets under management?: Flerie manages approximately €300M in assets under management.
When was Flerie founded?: Flerie was founded in 2011.
What sectors does Flerie invest in?: Flerie invests across Healthcare.
What are Flerie's recent exits?: Recent realized exits by Flerie include: Cobra Biologics (2020) to Cognate BioServices; Cormorant Pharmaceuticals (2016) to Bristol Myers Squibb.